A randomised controlled trial of the effect of a practice-based genetic screening facilitator.

ISRCTN ISRCTN16886710
DOI https://doi.org/10.1186/ISRCTN16886710
Secondary identifying numbers PSI03-26
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
04/12/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Michael Modell
Scientific

Primary Care & Population Sciences
Royal Free & University College Medical School
Level 2
Holborn Union Building
London
N19 3UA
United Kingdom

Phone +44 (0)20 7 288 3247
Email m.modell@ucl.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeScreening
Scientific title
Study objectivesTo investigate the feasibility of improving screening for carriers of the recessively inherited haemoglobin disorders (thalassaemia and sickle cell disorders) in general practice, by using a nurse facilitator to work with primary care teams and the relevant haematology laboratories. To identify problems in communication between all those involved in delivering the service, and to implement solutions.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedGenetic screening for haemoglobin disorders
InterventionThe 13 intervention practices were given: posters, and leaflets to explain to the members of the relevant ethnic groups why carrier testing is advisable and how it can be obtained, an aide-memoire card for GPs¿ consulting rooms listing groups to whom screening should be offered, and a practice reference manual containing background information. Intervention practices were offered three formal practice-based 30-60 minute training sessions from the nurse facilitator during the intervention year. Screening requests from study, control and non-participating practices were recorded using computerised hospital haematology laboratory records.
Intervention typeOther
Primary outcome measureThe main outcome measure was the change in the number of requests for screening tests for haemoglobin disorders made by control and intervention practices in the baseline and intervention years. We also recorded the numbers of requests from the non-participating practices. For the 2 year follow-up trial the main outcome measure was the number of requests for screening tests from each intervention practice in 1997 and 1998.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/04/1995
Completion date01/04/1997

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participantsRandomised at practise level, 13 intervention practices, 13 control practices
Key inclusion criteriaIt took place in an area of North London where 29% of residents and 43% of births are in the ethnic groups at risk for haemoglobin disorders (mainly Camden, Islington, Haringey and Enfield). Twenty six of the 93 practices using the services of the Whittington haematology laboratory agreed to take part, and were divided into 13 control and 13 intervention practices.
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/04/1995
Date of final enrolment01/04/1997

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Primary Care & Population Sciences
London
N19 3UA
United Kingdom

Sponsor information

Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Primary and Secondary Care Interface National Research and Development Programme (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 19/09/1998 Yes No